129 filings
8-K
ITCI
Intra-Cellular Therapies Inc
7 May 24
Intra-cellular Therapies Reports First Quarter 2024 Financial Results
7:40am
8-K
ITCI
Intra-Cellular Therapies Inc
24 Apr 24
Other Events
4:20pm
8-K
ITCI
Intra-Cellular Therapies Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:25pm
8-K
ITCI
Intra-Cellular Therapies Inc
16 Apr 24
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:40pm
8-K
ITCI
Intra-Cellular Therapies Inc
16 Apr 24
Lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints
7:10am
8-K
ql4axad4zgl66tv45m
1 Apr 24
Other Events
5:15pm
8-K
lxxmo3pe8lx1e8lebi3c
19 Mar 24
Intra-cellular Therapies Announces Executive Appointments and Leadership Changes
8:44am
8-K
cg6a44ojt7tk
22 Feb 24
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Corporate Update
7:39am
8-K
rbt58j
2 Nov 23
Intra-cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
8:01am
8-K
gxx qk8kjnqr05
3 Aug 23
Intra-cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
7:39am
8-K
shgefrkewh13rir59vf
23 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
z7zt9eo
4 May 23
Intra-cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:37am
8-K
b2156m53tm
28 Mar 23
Other Events
7:12am
8-K
mp3zpdkqvw4sfbi
1 Mar 23
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2022 Financial Results and Provides Corporate Update
7:41am
8-K
iu287oxg aev3w
9 Jan 23
Entry into a Material Definitive Agreement
5:13pm
8-K
pit 7qioqi8exs75
22 Dec 22
Entry into a Material Definitive Agreement
4:09pm
8-K
tcw3qbdo6grrktec9fb
3 Nov 22
Intra-cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:35am
8-K
hqf2c2 fb
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
8-K
9vz7988gi9
13 Jun 22
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
utq yei1hpuixiwqovs
10 May 22
Intra-cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:37am